MGI records money transfer revenue growth of 5% led by 10% YoY growth while MGO cross-border transaction sees 176% YoY growth.
Shares of MoneyGram International,...
BLRX trades on heavy volume after compelling Phase 3 Trials of Motixafortide (BL-8040) for the cancer treatment.
BioLineRx Ltd. (BLRX), a clinical-stage biopharmaceutical firm announced today that...
SRRK reached the all-time high after the close of the market on Tuesday as the stock skyrocketed on positive SRK-015 results.
Scholar Rock Holding Corporation...
MGI records money transfer revenue growth of 5% led by 10% YoY growth while MGO cross-border transaction sees 176% YoY growth.
Shares of MoneyGram International,...
BLRX trades on heavy volume after compelling Phase 3 Trials of Motixafortide (BL-8040) for the cancer treatment.
BioLineRx Ltd. (BLRX), a clinical-stage biopharmaceutical firm announced today that...
SRRK reached the all-time high after the close of the market on Tuesday as the stock skyrocketed on positive SRK-015 results.
Scholar Rock Holding Corporation...
In collaboration with Qorvo Biotechnologies, Zomedica Pharmaceuticals Corp plans to develop three new assays for the diagnosis of canine gastrointestinal issues.
Zomedica Pharmaceuticals Corp. (ZOM)...
MGI records money transfer revenue growth of 5% led by 10% YoY growth while MGO cross-border transaction sees 176% YoY growth.
Shares of MoneyGram International,...
BLRX trades on heavy volume after compelling Phase 3 Trials of Motixafortide (BL-8040) for the cancer treatment.
BioLineRx Ltd. (BLRX), a clinical-stage biopharmaceutical firm announced today that...
